8 Oct 2010 17:25
Phorm, Inc.
AIM Block Admission Update
08 October 2010
Phorm, Inc.
('Phorm' or the 'Company')
Block Admission Return
Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is
providing an update to its block admission filed on 9 April 2010 (the "Scheme").
For the period from 9 April 2010 to 8 October 2010, Phorm did not issue any securities under the Scheme and has the following balance of not yet issued securities under the Scheme:
| Name of Plan | Common shares originally admitted under the Scheme | Common shares issuable under the Scheme as of 8 October 2010 |
| 2003 Share Plan | 2,450,000 | 2,342,289 |
| 2009 EMI Option Plan | 250,000 | 250,000 |
| TOTAL | 2,700,000 | 2,592,289 |
As of 8 October 2010, the Company had an issued share capital of 18,479,907 common
shares with a par value of $0.001 each, of which 17,472,014 are trading on AIM under
the ticker PHRM, the restricted line and 1,007,893 are trading on AIM under the ticker PHRX, the unrestricted Line. A further 45,000 common shares are held in treasury.
About Phorm:
Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.
Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao Paulo and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com
Enquiries:
Phorm, Inc.
Andy Croxson (analysts & investors) +44 20 7297 2326
Alex Laity (media) +44 20 7297 2710
Citigate Dewe Rogerson +44 20 7638 9571
Justin Griffiths
Simon Rigby
Canaccord Genuity Limited +44 20 7050 6500
(Nominated Adviser)
Mark Williams
Andrew Chubb
PHRM.L (PHRM)